Thomas Larsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas Larsen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Frank Holden Mose
Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
2 shared publications - Jesper Nørgaard Bech
University Clinic in Nephrology and Hypertension, Gødstrup Hospital and Aarhus University, Herning, DENMARK
2 shared publications - Anna E Oczachowska-Kulik
Department of Medicine, Holstebro Hospital, Laegaardvej 12, Holstebro 7500, Denmark
1 shared publication - Anne Sp Kancir
University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark
1 shared publication - Annebirthe B Hansen
Department of Clinical Biochemistry, Holstebro Hospital, Holstebro, Denmark
1 shared publication - Bartlomiej Jonczy
Department of Medicine, Holstebro Hospital, Laegaardvej 12, Holstebro 7500, Denmark
1 shared publication
Latest Publications
- Open Access
- 24 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 50
Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial
Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relation exists has yet to be established. The aim of this study was to test the hypothesis that cholecalciferol supplementation improves cardiac function and reduces blood pressure (BP) and pulse wave velocity (PWV) in patients on chronic dialysis.
- 24 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 50
Open AccessCardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial
Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relation exists has yet to be established. The aim of this study was to test the hypothesis that cholecalciferol supplementation improves cardiac function and reduces blood pressure (BP) and pulse wave velocity (PWV) in patients on chronic dialysis.
- Open Access
- 26 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 163
Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial
Vitamin D receptor activators reduce albuminuria, and may improve survival in chronic kidney disease (CKD). Animal studies suggest that these pleiotropic effects of vitamin D may be mediated by suppression of renin. However, randomized trials in humans have yet to establish this relationship.
- 26 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 163
Open AccessEffect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial
Vitamin D receptor activators reduce albuminuria, and may improve survival in chronic kidney disease (CKD). Animal studies suggest that these pleiotropic effects of vitamin D may be mediated by suppression of renin. However, randomized trials in humans have yet to establish this relationship.
- 23 April 2012
- Vol. 174 (17) , 1159-60
[Improved prognosis in light chain nephropathy due to multiple myeloma].
A 64 year-old woman with acute renal failure and cast nephropathy due to excessive production of lambda free light chains received chemotherapy (using bortezomib and dexamethason) and haemodialysis with a high cut off-filter. The concentration of free light chains was markedly reduced after a fortnight. Nine months after admission, the patient's kidney function had improved and dialysis was stopped. Three months later, she got an autologous stem cell transplantation. One year later, estimated glomerular filtration rate was 25 ml/min, and the production of free light chains was under control.
- 23 April 2012
- Vol. 174 (17) , 1159-60
[Improved prognosis in light chain nephropathy due to multiple myeloma].
A 64 year-old woman with acute renal failure and cast nephropathy due to excessive production of lambda free light chains received chemotherapy (using bortezomib and dexamethason) and haemodialysis with a high cut off-filter. The concentration of free light chains was markedly reduced after a fortnight. Nine months after admission, the patient's kidney function had improved and dialysis was stopped. Three months later, she got an autologous stem cell transplantation. One year later, estimated glomerular filtration rate was 25 ml/min, and the production of free light chains was under control.